We Begin 2024 With...
609 Injectable Drug Monographs
Over 3,313 Peer Reviewed References
In 2023 we added:
6 New Intravenous Drugs
New Compatibility Information for 200 Drugs
New Stability Information for 20 Drugs
View a complete list of the updates to the King Guide since 2005.
2024 is the 53rd year that the King® Guide to Parenteral Admixtures® has been the leading source of the most up-to-date IV drug compatibility and stability information in hospital pharmacy practice worldwide. In those 53 years, Dr. James King and Dr. Patrick Catania have been the only editors of the King Guide and have made carefully crafted updates every quarter using painstaking and time-tested methods for data collection and reporting. No other references can claim this kind of consistency in information compilation.
Drug safety, improved patient outcomes, ensuring compliance and eliminating costly errors have always been our top priorities. Using the latest technology and a consistent editorial team benefits practitioners' ability to analyze continuously updated information without sacrificing convenience and mobility.
We strive to include in the King® Guide to Parenteral Admixtures® only that information which has been published in peer reviewed and refereed journals or information that is provided by the manufacturer. We believe that by using only data that have been reviewed via the professional literature, we insure the accuracy of the content of King Guide. Unpublished results that have not had the benefit of scholarly review are inadequate and other references that rely heavily on unpublished results should be scrutinized cautiously.
In this update we added a new monograph for REMDESIVIR.
We also added new stability information to the monographs for EPINEPHRINE HYDROCHLORIDE and REMDESIVIR.New compatibility information was added to the existing drug monograph FOR ALPROSTADIL, AMPICILLIN SODIUM, AMPICILLIN SODIUM – SULBACTAM SODIUM, BUMETANIDE, CEFEPIME HYDROCHLORIDE, CISATRACURIUM BESYLATE, DEXMEDETOMIDINE HYDROCHLORIDE, EPINEPHRINE HYDROCHLORIDE, FENTANYL CITRATE, FUROSEMIDE, HEPARIN SODIUM, HYDROMORPHONE HYDROCHLORIDE, KETAMINE HYDROCHLORIDE, MORPHINE SULFATE, OCTREOTIDE ACETATE, PIPERACILLIN AND TAZOBACTAM, SILDENAFIL CITRATE, TOTAL PARENTERAL NUTRITION SOLUTIONS, VANCOMYCIN HYDROCHLORIDE, and VASOPRESSIN.
Access from any computer, tablet, or phone makes decision making available where it's needed most - at the point of care. Full text monographs include route, dosage, temperature, and containers used to determine the stability and compatibility of over 600 injectable drugs.
TJC endorsed, our laminated wall charts are ideal for the pharmacy or nurses stations. Reports y-site compatibility of 122 drugs and 4 infusion fluids. Available in English and French.
The original King Guide and with quarterly updates still the best way to maintain rapidly changing information in print. Full text monographs include route, dosage, temperature, and containers used to determine the stability and compatibility of over 600 injectable drugs in a four-volume loose-leaf reference.
For HIT vendors and hospitals. Add significant value to existing systems by incorporating the King Guide Database.